-
Randomized controlled trial comparing exercise to health education for stimulant use disorder: Results from the CTN-0037 STimulant Reduction Intervention Using Dosed Exercise (STRIDE) study.
Trivedi MH, Greer TL, Rethorst CD, Carmody T, Grannemann BD, Walker NR, Warden D, Shores-Wilson K, Stoutenberg M, Oden NL, Silverstein M, Hodgkins C, Love LD, Seamans C, Stotts AL, Causey T, Szucs-Reed RP, Rinaldi P, Myrick H, Straus M, Liu DS, Lindblad R, Church T, Blair SN, Nunes EV. Randomized controlled trial comparing exercise to health education for stimulant use disorder: Results from the CTN-0037 STimulant Reduction Intervention Using Dosed Exercise (STRIDE) study. Journal of Clinical Psychiatry 2017; 78(8):1075-1082.
-
Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan.
Chang K, Wang J, Saxon AJ, Matthews AG, Woody GE, Hser Y. Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan. International Journal of Drug Policy 2017;45:1-6.
-
Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the Achieving Cannabis Cessation-Evaluating N-acetylcysteine Treatment (ACCENT) study.
Sherman BJ, McRae-Clark AL, Baker NL, Sonne SC, Killeen TK, Cloud K, Gray KM. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the Achieving Cannabis Cessation-Evaluating N-acetylcysteine Treatment (ACCENT) study. American Journal on Addictions 2017;26(2):136-144.
-
Drug abuse staff and clients smoking together: A shared addiction.
Guydish JR, Le T, Campbell BK, Yip D, Ji S, Delucci KL. Drug abuse staff and clients smoking together: A shared addiction. Journal of Substance Abuse Treatment 2017;76:64-68.
-
Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST.
Schwartz RP, McNeely J, Wu L, Sharma G, Wahle A, Cushing C, Nordeck C, Sharma A, O'Grady KE, Gryczynski J, Mitchell SG, Ali RL, Marsden J, Subramaniam GA. Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST. Journal of Substance Abuse Treatment 2017;76:69–76.
-
Distinctive trajectories of opioid use over an extended follow-up of patients in a multisite trial on buprenorphine + naloxone and methadone.
Hser Y, Huang D, Saxon AJ, Woody G, Moskowitz AL, Matthews AG, Ling W. Distinctive trajectories of opioid use over an extended follow-up of patients in a multisite trial on buprenorphine + naloxone and methadone. Journal of Addiction Medicine 2017;11(1):63-69.
-
Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction.
Worley MJ, Heinzerling KG, Shoptaw S, Ling W. Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction. Addiction 2017;112(7):1202-1209.
-
Generalizability of findings from randomized controlled trials: Application to the National Institute of Drug Abuse Clinical Trials Network.
Susukida R, Crum RM, Ebnesajjad C, Stuart EA, Mojtabai R. Generalizability of findings from randomized controlled trials: Application to the National Institute of Drug Abuse Clinical Trials Network. Addiction 2017;112(7):1210-1219.
-
Efficacy of motivational enhancement therapy to decrease alcohol and illicit-drug use in pregnant substance users reporting baseline alcohol use.
Osterman R, Lewis DF, Winhusen TJ. Efficacy of motivational enhancement therapy to decrease alcohol and illicit-drug use in pregnant substance users reporting baseline alcohol use. Journal of Substance Abuse Treatment 2017;77:150-155.
-
The role of behavioral interventions in buprenorphine maintenance treatment: A review.
Carroll KM, Weiss RD. The role of behavioral interventions in buprenorphine maintenance treatment: A review. American Journal of Psychiatry 2017;174(8):738-747.